Wendy Kao – REGiMMUNE

REGiMMUNE Featured in “China Times”

TAIPEI, June 4, 2024 – REGiMMUNE Limited is pleased to [...]

Wendy Kao2024-06-04T08:36:43+00:00June 4th, 2024|

TAIPEI, May 6, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-05-06T06:00:43+00:00May 6th, 2024|

TAIPEI, April 11, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-05-06T06:00:57+00:00April 15th, 2024|

TAIPEI, February 22, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-03-04T04:56:19+00:00March 1st, 2024|

TAIPEI, December 28, 2023 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2023-12-28T02:40:09+00:00December 27th, 2023|

Taipei, July 6, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]

Wendy Kao2023-07-07T06:43:34+00:00July 7th, 2023|

Taipei, March 29, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]

Wendy Kao2023-04-24T08:46:44+00:00March 30th, 2023|

RGI-2001 was well tolerated and associated with a meaningful reduction [...]

Wendy Kao2022-12-20T08:25:07+00:00December 19th, 2022|

TAIPEI, November 3, 2022 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2022-12-19T02:38:13+00:00November 7th, 2022|

Taipei, 16 May 2022 – REGiMMUNE Limited, a biopharmaceutical company [...]

Wendy Kao2022-05-16T09:32:24+00:00May 16th, 2022|